. 2017 Oct 17;7:13356. doi: 10.1038/s41598-017-13470-5

Table 4.

Detailed information of validated interactions from literatures.

microRNAs	Genes	Cancers	Techniques
hsa-let-7a-5p	DICER1	BRCA^74,75	1, 4
hsa-let-7a-5p	HMGA1	BRCA^74,75	2, 4
hsa-miR-10a-5p	EPHA4	LIHC⁷⁶	2, 4
hsa-miR-17-5p	HBP1	BRCA^77,78	1, 2, 4
	MYC	BRCA^77,78
	UBE2C	STAD⁷⁹
hsa-miR-181a-5p	DDX3X	UCEC⁸⁰	2, 4
hsa-miR-193b-3p	CCND1	PAAD⁸¹	1, 2, 4
	YWHAZ	PAAD⁸¹	1, 2, 4
	CCND1	STAD⁸²	3, 4
hsa-miR-196a-5p	FOXO1	LUAD⁸³	1, 4
	HOXA7	LUAD⁸⁴	3, 4
	HOXB8	LUAD/LUSC⁸⁴
	HOXC8	LUAD/LUSC⁸⁴
hsa-miR-196b-5p	HOXC8	BRCA⁸⁵	1, 3, 4
hsa-miR-196b-5p	HOXC8	LUSC⁸⁵	1, 3, 4
hsa-miR-200c-3p	ZEB1	BRCA⁸⁶	1, 2, 3, 4
		KIRC/KIRP⁸⁷
		LIHC⁸⁸
		LUAD/LUSC⁸⁹
		PAAD⁹⁰
		STAD⁹¹
		UCEC⁹²
hsa-miR-210-5p	ISCU	LIHC⁹³	1, 3, 4
hsa-miR-210-5p	ISCU	LUAD/LUSC⁹⁴	1, 3, 4
hsa-miR-221-3p	ATXN1	BRCA^95–97	1, 3, 4
hsa-miR-221-3p	BCL2L11	BRCA^95–97	1, 3, 4
hsa-miR-222-3p	PPP2R2A	LUSC^98,99	3, 4
hsa-miR-23b-3p	PSAP	LUSC¹⁰⁰	1, 2, 3, 4
hsa-miR-26a-5p	HSPA8	BRCA¹⁰¹	2, 4
hsa-miR-30c-5p	MTDH	LUAD/LUSC¹⁰²
hsa-miR-30c-5p	RAB18	LUAD¹⁰³
hsa-miR-30d-5p	HOXA11	UCEC¹⁰⁴	2, 4
hsa-miR-320a	MYC	LIHC¹⁰⁵	1, 2, 4
hsa-miR-320a	VDAC1	UCEC¹⁰⁶	1, 2, 4
hsa-miR-424-5p	WEE1	KIRC¹⁰⁷	1, 2, 4
hsa-miR-744-5p	TGFB1	KIRC/ KIRP¹⁰⁸	2, 4

Validation Techniques: (1) Luciferase reporter assay, (2) quantitative RT-PCR, (3) Western blot analysis, (4) miRNA transfection.